NIMC
GSK icon

NWQ Investment Management Company’s GSK GSK Stock Holding History

NWQ Investment Management Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$76.5M Buy
1,626,730
+57,119
+4% +$2.86M 3.46% 1
2020
Q2 		$80K Sell
1,569,611
-32,869
-2% -$1.69M 2.68% 3
2020
Q1 		$75.9M Buy
1,602,480
+102
+0% +$5.44K 3.05% 3
2019
Q4 		$94.1M Sell
1,602,378
-6,596
-0.4% -$367K 2.34% 3
2019
Q3 		$85.8M Buy
1,608,974
+7,141
+0.4% +$367K 2.08% 5
2019
Q2 		$80.1M Buy
1,601,833
+69,266
+5% +$3.48M 1.8% 8
2019
Q1 		$80.1M Buy
1,532,567
+26,272
+2% +$1.31M 1.74% 7
2018
Q4 		$28.1M Sell
1,506,295
-93,719
-6% -$4.62M 0.66% 72
2018
Q3 		$79.4M Sell
1,600,014
-119,977
-7% -$6.1M 1.57% 6
2018
Q2 		$86.7M Sell
1,719,991
-474,763
-22% -$23.9M 1.56% 11
2018
Q1 		$107M Buy
2,194,754
+80,413
+4% +$3.74M 1.73% 7
2017
Q4 		$93.7M Sell
2,114,341
-68,425
-3% -$3.16M 1.22% 14
2017
Q3 		$111M Buy
2,182,766
+186,951
+9% +$9.48M 1.36% 10
2017
Q2 		$108M Sell
1,995,815
-58,917
-3% -$3.14M 1.49% 10
2017
Q1 		$111M Buy
2,054,732
+322
+0% +$16.3K 1.46% 11
2016
Q4 		$98.9M Sell
2,054,410
-72,114
-3% -$3.56M 1.34% 16
2016
Q3 		$115M Buy
2,126,524
+466,374
+28% +$25.6M 1.67% 9
2016
Q2 		$89.9M Buy
1,660,150
+1,261,658
+317% +$66.5M 1.54% 16
2016
Q1 		$20.2M Buy
398,492
+22,628
+6% +$1.13M 0.31% 92
2015
Q4 		$19M Buy
375,864
+6,220
+2% +$317K 0.29% 96
2015
Q3 		$17.8M Sell
369,644
-38,756
-9% -$2.02M 0.27% 95
2015
Q2 		$21.3M Buy
408,400
+43,296
+12% +$2.44M 0.29% 96
2015
Q1 		$21.1M Buy
365,104
+201,404
+123% +$11.5M 0.26% 92
2014
Q4 		$8.74M Sell
163,700
-2,800
-2% -$157K 0.1% 109
2014
Q3 		$9.57M Buy
166,500
+47,420
+40% +$2.91M 0.11% 113
2014
Q2 		$7.96M Buy
119,080
+40
+0% +$2.71K 0.08% 113
2014
Q1 		$7.95M Sell
119,040
-48,420
-29% -$3.27M 0.07% 115
2013
Q4 		$11.2M Sell
167,460
-1,980
-1% -$128K 0.1% 106
2013
Q3 		$10.6M Hold
169,440
– – 0.1% 95
2013
Q2 		$10.6M Buy
+169,440
New +$10.8M 0.09% 89

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

NWQ Investment Management Company's GSK Position: Q3 2020 in Review

NWQ Investment Management Company increased its GSK (GSK) stake by 3.6% in Q3 2020, buying an estimated $2.86M and bringing the position to 1,626,730 shares worth $76.5M. The position accounts for 3.46% of the portfolio, ranked #1.

NWQ Investment Management Company first reported a position in GSK in Q2 2013 and has held it in 30 quarters since. The position peaked at $115M in Q3 2016. 827 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

  • NWQ Investment Management Company held 1,626,730 shares of GSK worth $76.5M as of Q3 2020.
  • NWQ Investment Management Company bought 57,119 GSK shares in Q3 2020, an estimated $2.86M.
  • GSK made up 3.46% of NWQ Investment Management Company's portfolio in Q3 2020, its #1 holding.
  • NWQ Investment Management Company first reported a position in GSK in Q2 2013 and has held it in 30 quarters since.
  • NWQ Investment Management Company's GSK position peaked at $115M in Q3 2016.
  • 827 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.